22 May 2024
Marks and Spencer Group Plc Full Year Results for 52 Weeks Ended 30 March 2024 “THE BEGINNINGS OF A NEW M&S” Another year of…
21 May 2024
21 May 2024 Pennon Group plc Full Year Results 2023/24 Pennon Group plc (‘Pennon’ or ‘the Group’) today announces its results for the full…
21 May 2024 Watkin Jones plc (the ‘Group’) HY Results for the six months ended 31 March 2024 Continued operational progress, positioning for market…
CRANSWICK plc: PRELIMINARY RESULTS A year of strong financial and strategic progress 21 May 2024 Cranswick plc (“Cranswick” or “the Company” or “the Group”),…
Caledonia Investments plc Final results for the year ended 31 March 2024 Financial highlights Year Year 31 March 2024 31 March 2023…
Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be…
21 May 2024 Assura plc Good operational and strategic progress; further dividend increase announced Assura plc (“Assura”), the specialist healthcare property investor and developer,…
Issued: 21 May 2024, London UK GSK announces positive results from phase III severe asthma trials of depemokimab · Primary endpoints met in SWIFT-1 and SWIFT-2 trials…